The meeting will focus on aspects of Candidate Selection. Examples of topics to be discussed include the how current strategies impact on pharma productivity; is it possible to select more easily developable compounds; has attrition in DMPK/ADME been fully resolved; and the role of new delivery technologies in developing compounds without ideal drug like properties.